BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20350610)

  • 1. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles.
    Rutten CE; van Luxemburg-Heijs SA; van der Meijden ED; Griffioen M; Oudshoorn M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1282-92. PubMed ID: 20350610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.
    Rutten CE; van Luxemburg-Heijs SA; Halkes CJ; van Bergen CA; Marijt EW; Oudshoorn M; Griffioen M; Falkenburg JH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):40-8. PubMed ID: 22871556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation.
    van Balen P; van Luxemburg-Heijs SAP; van de Meent M; van Bergen CAM; Halkes CJM; Jedema I; Falkenburg JHF
    Transplantation; 2017 Dec; 101(12):2850-2854. PubMed ID: 28252558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
    Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
    Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
    Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
    Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
    Madrigal A; Shaw BE
    Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.
    Zino E; Frumento G; Marktel S; Sormani MP; Ficara F; Di Terlizzi S; Parodi AM; Sergeant R; Martinetti M; Bontadini A; Bonifazi F; Lisini D; Mazzi B; Rossini S; Servida P; Ciceri F; Bonini C; Lanino E; Bandini G; Locatelli F; Apperley J; Bacigalupo A; Ferrara GB; Bordignon C; Fleischhauer K
    Blood; 2004 Feb; 103(4):1417-24. PubMed ID: 14576061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
    Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
    J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactive feature of HLA-DP-specific cytotoxic T-cell clone.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Cell Immunol; 1994 Jan; 153(1):262-70. PubMed ID: 7904540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
    Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
    Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.
    Arrieta-Bolaños E; Crivello P; Metzing M; Meurer T; Ahci M; Rytlewski J; Vignali M; Yusko E; van Balen P; Horn PA; Falkenburg JHF; Fleischhauer K
    Front Immunol; 2018; 9():280. PubMed ID: 29520276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation.
    Shaw BE; Potter MN; Mayor NP; Pay AL; Smith C; Goldman JM; Prentice HG; Marsh SG; Madrigal JA
    Bone Marrow Transplant; 2003 Jun; 31(11):1001-8. PubMed ID: 12774051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants.
    Laux G; Mansmann U; Deufel A; Opelz G; Mytilineos J
    Transplantation; 2003 May; 75(9):1527-32. PubMed ID: 12792509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion.
    Stevanovic S; van Bergen CA; van Luxemburg-Heijs SA; van der Zouwen B; Jordanova ES; Kruisselbrink AB; van de Meent M; Harskamp JC; Claas FH; Marijt EW; Zwaginga JJ; Halkes CJ; Jedema I; Griffioen M; Falkenburg JH
    Blood; 2013 Sep; 122(11):1963-73. PubMed ID: 23777765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
    Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
    Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
    Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference.
    Nicholson I; Varney M; Kanaan C; Grigg A; Szer J; Tiedemann K; Tait BD
    Hum Immunol; 1997 Jul; 55(2):163-9. PubMed ID: 9361968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain.
    Lauterbach N; Crivello P; Wieten L; Zito L; Groeneweg M; Voorter CE; Fleischhauer K; Tilanus MG
    Mol Immunol; 2014 May; 59(1):19-29. PubMed ID: 24462895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.